BMO Capital Markets reaffirmed its “Market Perform” rating and $64.00 price target for Novo Nordisk A/S (NYSE:NVO) following the announcement of a CEO transition. Analysts view the leadership change ...

F5, Inc. (NASDAQ:FFIV) announced an enhanced partnership with Red Hat, the leading provider of open-source solutions, aimed ...